Management of Patients With Keratoconus With Intacs
Primary Purpose
Keratoconus
Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Intacs
Sponsored by
About this trial
This is an interventional treatment trial for Keratoconus focused on measuring keratoconus, Intacs
Eligibility Criteria
Inclusion Criteria:
- All patients had clear central corneas and contact lens intolerance (rigid gas permeable contact lenses intolerance, frequent contact lens displacement, unsatisfactory visual acuity),
Exclusion Criteria:
- history of herpes keratitis; diagnosed autoimmune disease; and systemic connective tissue disease.
Sites / Locations
Outcomes
Primary Outcome Measures
refractive stability, UCVA, BSCVA, complications
Secondary Outcome Measures
Full Information
NCT ID
NCT00384501
First Posted
October 5, 2006
Last Updated
October 5, 2006
Sponsor
University Hospital of Crete
1. Study Identification
Unique Protocol Identification Number
NCT00384501
Brief Title
Management of Patients With Keratoconus With Intacs
Official Title
Intacs for the Treatment of Keratoconus
Study Type
Interventional
2. Study Status
Record Verification Date
October 2006
Overall Recruitment Status
Terminated
Study Start Date
January 2000 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital of Crete
4. Oversight
5. Study Description
Brief Summary
Purpose To evaluate long-term follow up of Intacs microthin prescription inserts (Addition Technology Inc, Fremont, Calif) for the management of keratoconus.
Design A long-term (five years) retrospective, follow-up study
Detailed Description
Subjects and Methods
Ethical committee approval was obtained for the original trial, and patients were asked to sign an informed consent form (in accordance with Institutional guidelines and to the Declaration of Helsinki) before treatment and for further follow-up examinations. The registration information for this clinical trial is available to the public through the National Institute of Health database.
The surgical procedure was done under topical anesthesia. Two Intacs segments of 0.45-mm thickness were inserted so as to embrace the steepest keratoconus meridian, according to the topographic image, aiming at maximal flattening.
The corneal thickness was measured intraoperatively at the incision site and peripherally in the cornea along the ring placement markings with ultrasonic pachymetry (Sonogage, Cleveland, Ohio, USA). Using a diamond knife, set at 70% of the thinnest corneal measurement, a 0.9-mm radial incision was formed, and corneal pockets were created using two Sinskey hooks and a Suarez spreader. Two corneal tunnels were then formed using clockwise and counterclockwise dissectors under suction created by a vacuum-centering guide. The two polymethyl methacrylate (PMMA) segments (0.45-mm thickness) were implanted in the respective corneal tunnels, maintaining a space of approximately 2.0-mm between their ends and 1.5 mm between the opposite edge of each segment and the edge of the incision. The incision site was sutured using a single 10/0 nylon stitch.
Postoperative evaluation Postoperatively, all eyes received antibiotic/steroid combination eye drops 4 times per day for 2 weeks. In addition, all patients were instructed to use preservative-free artificial tears frequently. The sutures were removed 2 weeks after surgery.
Group differences for continuous variables were tested using the paired Student t tests. The change in manifest refraction (spherical equivalent) (MRSE) and topographic k values and topographic astigmatism were plotted over time to determine long-term stability, and the difference as a function of time was analyzed using paired 2-tailed t tests (at time intervals of preoperative to 1 month, 1 to 3 months, 3 to 6 months, 6 to 12 months, and every year of follow up period). Results are presented as means + standard deviation [SD]. A P value less than .05 was regarded as statistically significant.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Keratoconus
Keywords
keratoconus, Intacs
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
25 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Intacs
Primary Outcome Measure Information:
Title
refractive stability, UCVA, BSCVA, complications
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All patients had clear central corneas and contact lens intolerance (rigid gas permeable contact lenses intolerance, frequent contact lens displacement, unsatisfactory visual acuity),
Exclusion Criteria:
history of herpes keratitis; diagnosed autoimmune disease; and systemic connective tissue disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
George D Kymionis, M.D., Ph.D
Organizational Affiliation
University of Crete
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
16814056
Citation
Alio JL, Shabayek MH, Artola A. Intracorneal ring segments for keratoconus correction: long-term follow-up. J Cataract Refract Surg. 2006 Jun;32(6):978-85. doi: 10.1016/j.jcrs.2006.02.044.
Results Reference
result
Learn more about this trial
Management of Patients With Keratoconus With Intacs
We'll reach out to this number within 24 hrs